RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,709,000 | +25.9% | 112,579 | -4.5% | 0.00% | – |
| Q2 2022 | $2,152,000 | -67.7% | 117,944 | -61.0% | 0.00% | -100.0% |
| Q1 2022 | $6,656,000 | -86.8% | 302,682 | -77.9% | 0.00% | -87.5% |
| Q4 2021 | $50,332,000 | +7.6% | 1,370,317 | -9.1% | 0.01% | 0.0% |
| Q3 2021 | $46,798,000 | +11.4% | 1,507,203 | +14.1% | 0.01% | +14.3% |
| Q2 2021 | $41,999,000 | +88.4% | 1,321,135 | +31.6% | 0.01% | +75.0% |
| Q1 2021 | $22,288,000 | -7.1% | 1,003,979 | -17.3% | 0.00% | 0.0% |
| Q4 2020 | $23,980,000 | -53.4% | 1,214,190 | -24.0% | 0.00% | -63.6% |
| Q3 2020 | $51,412,000 | +49.8% | 1,596,657 | +35.0% | 0.01% | +37.5% |
| Q2 2020 | $34,328,000 | +35.4% | 1,182,932 | -0.8% | 0.01% | +14.3% |
| Q1 2020 | $25,357,000 | – | 1,192,121 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
| KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
| Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
| Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
| Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
| AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
| Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
| Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |